The reason I ask the question is because if you look at head and neck cancer patient survival data, it looks like at least 50-60% live 5 years. Does CVM have to wait that long for the trial to conclude?
Just in time for MK to go off patent! I wonder if the orphan status provides any protection to let them profit from it in H&N cancer. I think I understand that they are filing patents for other applications of it to help provide some protection?